Trump wants more mental health care; Alabama says it's trying AL.com Budget undercuts Trump focus on mental health, school safety Yahoo News Mental health awareness license plates offered by New York State DMV Buffalo News Trump wants to 'tackle the difficult issue of mental health?' He should put his money where his mouth is. Washington Post Full coverage
HHS Secretary Calls Idaho's Blatant Violation of Health Care Law a 'Cry for Help' New York Magazine Idaho 'Pushing Envelope' With Health Insurance Plan. Can It Do That? Kaiser Health News Idaho Insurer Moves Ahead With Health Plans That Flout Federal Rules NPR Full coverage
Florida shooting rampage sparks review of mental health restrictions on gun purchases USA TODAY Trump's Mental-Health Concern Trolling Won't End Mass Shootings Vanity Fair Trump Calls For Mental Health Action After Shooting; His Budget Would Cut Programs NPR Full coverage
Brainstorm Health: Roche Buys Flatiron, FDA Alzheimer's Guidance, Flu Vaccine Effectiveness Fortune Pharma giant Roche to acquire Flatiron Health for $1.9 billion ModernHealthcare.com Roche To Acquire Flatiron Health For $1.9 Billion Seeking Alpha Alphabet-backed Flatiron Health is being acquired by Roche CNBC Full coverage
Generic drugmakers, which have saved Americans hundreds of billions of dollars in the past decade with their low-cost, copycat medicines, don't think they should join other health industries to finance a health care overhaul. Under the Senate Finance Committee bill approved Tuesday, the generic drug industry would pay $460 million over a decade through additional rebates to the state-federal Medicaid program for the poor. "That would be very harmful to our industry and our consumers," said Kathleen Jaeger, the president and CEO of the Generic Pharmaceutical Industry Association. She said the higher discounts would result in fewer companies making generics, which could push prices higher. Brand-name drugmakers, which would pay $80 billion as part of the proposed health overhaul and support the Finance Committee bill, scoff at their rivals' complaints. "Generics are getting off pretty light while everyone else gets whacked," said Joe Kelley, a lobbyist...
Comments